What Happens When MHC Class I Expression is Altered in Cancer?
Many cancer cells evade immune detection by altering the expression of MHC Class I molecules. This can occur through downregulation or complete loss of MHC Class I expression, rendering CTLs unable to recognize and target these cells effectively. This immune evasion strategy is a significant obstacle in cancer immunotherapy, as it allows cancer cells to persist and proliferate without immune interference.
